146 related articles for article (PubMed ID: 1217964)
1. Blastic transformation of lymphocytes in in vitro cultures during immunosuppressive therapy in patients with glomerulonephritis.
Szewczyk Z; Klinger M; Melcer H; Falkiewicz K
Arch Immunol Ther Exp (Warsz); 1975; 23(3):367-78. PubMed ID: 1217964
[TBL] [Abstract][Full Text] [Related]
2. Blastic transformation of lymphocytes in in vitro cultures under the influence of phytohemagglutinin and pokeweek mitogen in patients with glomerulonephritis treated over long periods of time with immunosuppressive drugs.
Szewczyk Z; Klinger M; Melcer H
Arch Immunol Ther Exp (Warsz); 1976; 24(1):137-42. PubMed ID: 1259531
[TBL] [Abstract][Full Text] [Related]
3. Response of lymphocytes to nonspecific mitogens (PHA, Con A, PWM) in patients with glomerulonephritis.
Klinger M
Arch Immunol Ther Exp (Warsz); 1980; 28(2):225-40. PubMed ID: 7447635
[TBL] [Abstract][Full Text] [Related]
4. The effect of immunosuppressive and anti-inflammatory drugs on lymphocyte population and MIF in glomerulonephritis.
Janas-Boratyńska M; Szewczyk Z
Arch Immunol Ther Exp (Warsz); 1979; 27(6):833-45. PubMed ID: 398689
[TBL] [Abstract][Full Text] [Related]
5. The effects of azathioprine and prednisolone on T- and B-lymphocytes in patients with lupus nephritis and chronic glomerulonephritis.
Tareyeva IE; Shilov EM; Gordovskaya NB
Clin Nephrol; 1980 Nov; 14(5):233-7. PubMed ID: 6971722
[TBL] [Abstract][Full Text] [Related]
6. [Results of immunosuppressive therapy of chronic glomerulonephritis in 400 patients].
Müller V; Natusch R; Göbel U; Laske HR; Sperschneider H; Pap I; Sinn W; Koall W; Achenbach H; Tredt HJ
Z Urol Nephrol; 1985 Jan; 78(1):39-55. PubMed ID: 3976309
[TBL] [Abstract][Full Text] [Related]
7. [Changes in the cellular-humoral immune reactivity of patients with lupus nephritis and chronic glomerulonephritis treated with corticosteroids or corticosteroids and imuran].
Stefanova G; Mikhaĭlova A; Gavrilov G; Naumova E; Bŭchvarova E
Vutr Boles; 1983; 22(5):65-71. PubMed ID: 6673336
[TBL] [Abstract][Full Text] [Related]
8. [Effect of prednisolone and azathioprine on T- and B-lymphocyte number in peripheral blood of patients with glomerulonephritis and systemic lupus erythematosus].
Shilov EM; Tareeva IE; Gordovskaia NB
Ter Arkh; 1978; 50(6):60-7. PubMed ID: 307828
[No Abstract] [Full Text] [Related]
9. Blastic transformation of lymphocytes from patients with glomerulonephritis in in vitro cultures.
Szewczyk Z
Arch Immunol Ther Exp (Warsz); 1970; 18(5):543-56. PubMed ID: 4099656
[No Abstract] [Full Text] [Related]
10. [Immunosuppressive therapy of glomerulonephritis--controlled studies].
Ferrari P; Frey FJ
Ther Umsch; 1993 Feb; 50(2):119-29. PubMed ID: 8456416
[TBL] [Abstract][Full Text] [Related]
11. [Lymphocyte transformation during immunosuppressive therapy of lupus erythematosus visceralis].
Heine KM; Klatt R; Stobbe H; Apostoloff E; Jendrusch C
Z Gesamte Inn Med; 1969 Jan; 24(1):Suppl:152-4. PubMed ID: 5402572
[No Abstract] [Full Text] [Related]
12. Blastic transformation of lymphocytes in patients with glomerulonephritis.
Szewczyk Z; Melcher H; Klinger M
Arch Immunol Ther Exp (Warsz); 1975; 23(5):617-23. PubMed ID: 1217967
[No Abstract] [Full Text] [Related]
13. [Effect of estrogen on the blast transformation of lymphocytes and interleukin-2 production in lupus erythematosus].
Pozsonyi T; Jakab L; Jakab L; Onody K; Cseh K; Kalabay L
Orv Hetil; 1992 May; 133(19):1167-71. PubMed ID: 1584598
[TBL] [Abstract][Full Text] [Related]
14. [Interferon therapy effects on activation of T-lymphocytes in patients with systemic lupus erythematosus].
Stanislav ML; Balabanova RM; Nikonova MF; Litvina MM; Iarilin AA
Ter Arkh; 2000; 72(5):44-9. PubMed ID: 11109620
[TBL] [Abstract][Full Text] [Related]
15. Mononuclear phagocytes from patients with active systemic lupus erythematosus down-regulate the specific in vitro reactivity of autologous lymphocytes to double-stranded DNA.
Weill BJ; Renoux ML
Clin Exp Immunol; 1988 Apr; 72(1):43-9. PubMed ID: 3293851
[TBL] [Abstract][Full Text] [Related]
16. Immunosuppressive therapy in lupus nephritis: the Euro-Lupus Nephritis Trial, a randomized trial of low-dose versus high-dose intravenous cyclophosphamide.
Houssiau FA; Vasconcelos C; D'Cruz D; Sebastiani GD; Garrido Ed Ede R; Danieli MG; Abramovicz D; Blockmans D; Mathieu A; Direskeneli H; Galeazzi M; Gül A; Levy Y; Petera P; Popovic R; Petrovic R; Sinico RA; Cattaneo R; Font J; Depresseux G; Cosyns JP; Cervera R
Arthritis Rheum; 2002 Aug; 46(8):2121-31. PubMed ID: 12209517
[TBL] [Abstract][Full Text] [Related]
17. Immunosuppressive treatment of the glomerulonephritis of systemic lupus.
Faedda R; Palomba D; Satta A; Pirisi M; Tanda F; Bartoli E
Clin Nephrol; 1995 Dec; 44(6):367-75. PubMed ID: 8719548
[TBL] [Abstract][Full Text] [Related]
18. Effect of combined immunosuppressive anticoagulant and antiplatelet therapy of the course of chronic mesangial-proliferative glomerulonephritis.
Matousovic K; Matl I; Zabka J; Zástava V; Rossmann P; Prát V
Czech Med; 1985; 8(3):151-7. PubMed ID: 3932033
[TBL] [Abstract][Full Text] [Related]
19. Immunosuppressive therapy in systemic lupus erythematosus.
Russell AS; Bretscher PA
J Rheumatol Suppl; 1987 Jun; 14 Suppl 13():194-8. PubMed ID: 3302253
[TBL] [Abstract][Full Text] [Related]
20. [Results of the treatment of mesangiocapillary glomerulonephritis].
Rodríguez JA; Olmos A; Ferrer E; Mauri JM; Capdevilla L; Codina S; Alsina J; Camps J; Piera L
Rev Clin Esp; 1975 Dec; 139(5):415-22. PubMed ID: 1215585
[No Abstract] [Full Text] [Related]
[Next] [New Search]
